The Weekly Litigation News Digest is now live. Subscribe now

Combination Medicament Comprising Il-12 And An Agent For Blockade Of T-Cell Inhibitory Molecules For Tumour Therapy - EP3351261

The patent EP3351261 was granted to Universitt Zrich on Jun 2, 2021. The application was originally filed on Oct 10, 2012 under application number EP18160057A. The patent is currently recorded with a legal status of "Revoked".

EP3351261

UNIVERSITT ZRICH
Application Number
EP18160057A
Filing Date
Oct 10, 2012
Status
Revoked
Jun 10, 2025
Publication Date
Jun 2, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

JAMES POOLEMar 2, 2022CARPMAELS & RANSFORDADMISSIBLE
KRAUS & LEDERER PARTGMBBMar 2, 2022HOFFMANN EITLEADMISSIBLE
WEINZIERLMar 2, 2022SCHIWECK WEINZIERL KOCH PATENTANWALTE PARTNERSCHAFT MBBADMISSIBLE
SANOFIMar 2, 2022CMS CAMERON MCKENNA NABARRO OLSWANGWITHDRAWN
JG OPPOSITIONSMar 1, 2022DRYWOODADMISSIBLE

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2011137289
OPPOSITIONEP1537878
OPPOSITIONUS2003118564
OPPOSITIONUS2009028857
OPPOSITIONUS5116964
OPPOSITIONUS8008449
OPPOSITIONUS8067227
OPPOSITIONWO2006121168
OPPOSITIONWO2009014708
OPPOSITIONWO2011119773
OPPOSITIONWO2011161699
OPPOSITIONWO2013053775

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents